Primidone

CHEMBL856 Phase 4 Aprobado Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
218.2 g/mol
LogP
0.9
Phase
4

An anticonvulsant medication used to control certain types of seizures in epilepsy, and is also used to treat essential tremor, an involuntary shaking that affects the hands and other parts of the body. Part of the drug is converted in the body to phenobarbital, which contributes to its seizure-controlling effects.

Peso molecular

218,2500 g/mol

LogP

0,90

TPSA

58,20 Ų

Regla de cinco de Lipinski

Cumple

Áreas terapéuticas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estructura 2D

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

CCC1(c2ccccc2)C(=O)NCNC1=O

InChI

InChI=1S/C12H14N2O2/c1-2-12(9-6-4-3-5-7-9)10(15)13-8-14-11(12)16/h3-7H,2,8H2,1H3,(H,13,15)(H,14,16)

Molecular Formula

C12H14N2O2

HBD / HBA

2 / 2

Enlaces Rotables

2

Átomos Pesados

16

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Preguntas frecuentes

An anticonvulsant medication used to control certain types of seizures in epilepsy, and is also used to treat essential tremor, an involuntary shaking that affects the hands and other parts of the body. Part of the drug is converted in the body to phenobarbital, which contributes to its seizure-controlling effects.

Yes, Primidone is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL856. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 4909. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.

Aviso médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.